What to Expect From Red Hat Earnings
Red Hat is scheduled to report its fiscal fourth-quarter financial results after the markets close on Tuesday.
All Work
Chris Lange
Why JPMorgan Favors Nike Over Lululemon Now
JPMorgan has added athletic apparel and footwear giant Nike to its Analyst Focus list. At the same time, the firm removed Lululemon Atheletica from the list.
BioMarin Sinks Despite Meeting Primary Endpoint
BioMarin Pharmaceutical made waves early Monday following the release of late-stage results from its pegvaliase study.
Top 6 Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Petrobras, Nike and some of the major companies reporting their quarterly results this coming week.
How Analysts View Valeant After an Earnings Catastrophe
Releasing preliminary results may have been ill-advised to release, as the impact was absolutely catastrophic to Valeant Pharmaceuticals stock.
4 Key Biopharma Movers of the Past Week
Over the past week, Celator Pharmaceuticals and a few other biotech companies made impressive runs.
How Analysts View 3D Systems After Earnings
After 3D Systems reported fourth-quarter and full-year 2015 results early Monday, across the board analysts increased their price targets, showing some optimism for the stock.
5 Companies That Destroyed Shareholders Last Week
Although the markets have made their comeback, some stocks are still slowing that recovery and punishing their shareholders.
How Analysts View Adobe After Earnings
Overall, investors had a very positive reaction to the Adobe earnings report, but analysts had a somewhat mixed view.
Pfizer Posts Positive Late-Stage Results in Colitis Trials
Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in ulcerative colitis program at the 11th Congress of European Crohn's and Colitis Organization.
How Oppenheimer Sees Upside for Coming Apple Product Event
While Oppenheimer expects to see several "under the hood" improvements across Apple devices, it is not expecting the same exuberance as last year when the company shared final details of the Apple Watch.
Whole Foods Changes the Chicken Game
Whole Foods is changing the chicken game with its most recent move to replace its fast-growing chicken breeds with slower-growing breeds.
Major Banks Continue Expanding Share Repurchase Plans
While most of the major banks may have been hoping for a rate hike from the U.S. Federal Reserve, they are still closing out the week on a positive note.
Aeropostale Plans to Review Strategic and Financial Alternatives After Weak Earnings
The Aeropostale board of directors has authorized the "review of strategic and financial alternatives," meaning a sale or restructuring of the company.
Why Eagle Pharma Shares Are in Free Fall
Eagle Pharmaceuticals shares were in free fall early Friday after it received a Complete Response Letter from the FDA for its Kangio.
On Semiconductor Continues to Pursue Fairchild Merger With Tender Offer
ON Semiconductor has announced that it has extended its previously announced tender offer to purchase all the outstanding shares of Fairchild Semiconductor.
Aeropostale Earnings Continue Downward Spiral
Aéropostale, Inc. (NYSE: ARO) reported fiscal fourth quarter financial results after the markets closed on Thursday. The company had a net loss per share of $0.14 and $489 million in revenue compared to consensus…
Adobe Earnings Blow Away Investors
Adobe Systems Inc. (NASDAQ: ADBE) released fiscal second-quarter earnings results after the markets closed on Thursday. The company had $0.66 in earnings per share (EPS) on $1.38 billion in revenue compared to Thomson Reuters…
Hutchinson China MediTech Sets Price for US IPO
Hutchinson China MediTech will offer more than 7 million American depositary shares at $13.50 apiece in and IPO valued at up to more than $116 million.
How Analysts View FedEx After Earnings
24/7 Wall St. has collected some analysts reports on FedEx following the release of the earnings, and we have added in some highlights from the report as well.